Keytruda Extends Life for Those Fighting Hodgkin Lymphoma & It’s Now FDA-Approved as Treatment

Published Oct 19, 2020

Keytruda Extends Life for Those Fighting Hodgkin Lymphoma & It’s Now FDA-Approved as Treatment

People with relapsed or treatment-resistant classic Hodgkin Lymphoma now have FDA approval to use Keytruda. The immunotherapy treatment is proven to extend life.

NOW
PLAYING
R-CHOP Explained
NOW
PLAYING
New Drug Selinexor (Xpovio) Has Many Risks, Limited Benefits Against Non-Hodgkin Lymphoma
NOW
PLAYING
CAR T-Cell Therapy: Making Your Body a More Efficient Cancer Fighter
NOW
PLAYING
Exciting New Options Are Available for Lymphoma Recurrence
NOW
PLAYING
The Promise - and Risks - of CAR T-Cell Therapy
NOW
PLAYING
New Antibody-Based Drug is a ‘Great Stride’ Forward In Improving Non-Hodgkin Lymphoma Outcomes

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.